Screening for prediabetes and type 2 diabetesmellitus

JAMA - Journal of the American Medical Association

Volumn 315, Issue 7, 2016, Pages 697-698

  Laiteerapong, Neda ^a   Cifu, Adam S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; METFORMIN PLUS ROSIGLITAZONE;

AGE; BLINDNESS; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COMORBIDITY; DEMENTIA; DEPRESSION; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HEALTH CARE DELIVERY; HEART DISEASE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; KIDNEY FAILURE; LEG AMPUTATION; LIFESTYLE MODIFICATION; MEDICAL SERVICE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING TEST; SHORT SURVEY; SYSTEMATIC REVIEW; UNITED STATES; DIABETES MELLITUS, TYPE 2; GLUCOSE METABOLISM DISORDERS; MASS SCREENING;

DIABETES MELLITUS, TYPE 2; GLUCOSE METABOLISM DISORDERS; HUMANS; MASS SCREENING;

EID: 84958787176     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.17545     Document Type: Short Survey

References (10)

1. Centers for Disease Control and Prevention. 2014 National Diabetes Statistics Report. http://www.cdc .gov/diabetes/data/statistics/2014statisticsreport .html. Accessed October 29, 2015.
2. Morris DH, Khunti K, Achana F, et al. Progression rates from HbA1c 6.0-6.4%and other prediabetes definitions to type 2 diabetes. Diabetologia. 2013; 56(7):1489-1493.
3. Samuels TA, Cohen D, Brancati FL, et al. Delayed diagnosis of incident type 2 diabetes mellitus in the ARIC study. Am J Manag Care. 2006;12(12):717-724.
4. Siu AL; USPSTF. Screening for abnormal blood glucose and type 2 diabetesmellitus. Ann Intern Med. 2015;163(11):861-868.
5. Selph S, Dana T, Blazina I, et al. Screening for type 2 diabetes mellitus. Ann Intern Med. 2015;162 (11):765-776.
6. Li G, Zhang P,Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study. Lancet Diabetes Endocrinol. 2014;2(6):474-480.
7. Park P, Simmons RK, Prevost AT, Griffin SJ. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety. BMC Public Health. 2008;8:350.
8. Hoerger TJ, Crouse WL, Zhuo X, et al. Medicare's intensive behavioral therapy for obesity. Am J Prev Med. 2015;48(4):419-425.
9. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589.
10. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865.